Apr 1 |
Doximity falls amid short report from Jehoshaphat Research
|
Apr 1 |
Declining Stock and Solid Fundamentals: Is The Market Wrong About Doximity, Inc. (NYSE:DOCS)?
|
Mar 28 |
All You Need to Know About Doximity (DOCS) Rating Upgrade to Buy
|
Mar 19 |
Should You Hold Doximity (DOCS)?
|
Feb 23 |
20 Most Valuable Digital Health Companies In The US
|
Feb 22 |
Doximity to Participate in Upcoming Investor Events
|
Feb 21 |
2 Beaten-Down Stocks to Buy and Hold for 10 Years
|
Feb 21 |
1 Cash-Gushing Stock Down 70% to Buy and Hold Forever
|
Feb 21 |
Doximity: Rating Upgrade To Buy As Outlook Turns Positive
|
Feb 10 |
Doximity Third Quarter 2024 Earnings: Beats Expectations
|